Stay updated on CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial

Sign up to get notified when there's something new on the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Recruitment status on the study page now shows 'No longer looking for participants', signaling that enrollment is closed. The page also adds new help/navigation items ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'), updates the Intervention/Treatment heading formatting, and includes a revision note 'Revision: v3.6.0'.
    Difference
    0.2%
    Check dated 2026-06-14T05:24:53.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5, indicating a new site revision. No specific content changes are indicated by the provided changes.
    Difference
    0.0%
    Check dated 2026-06-07T02:19:41.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.5.3 to v3.5.4, indicating a new release of the site's backend or content management. This change does not alter trial information shown to users.
    Difference
    0.0%
    Check dated 2026-05-16T09:25:53.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from **v3.5.2** to **v3.5.3**, indicating a site/version refresh rather than a change to the study record.
    Difference
    0.0%
    Check dated 2026-04-25T05:21:56.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T23:57:32.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision: v3.5.0 deployed.
    Difference
    0.0%
    Check dated 2026-03-20T01:22:14.000Z thumbnail image

Stay in the know with updates to CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page.